Generation of human-induced pluripotent stem cells
- PMID: 18600223
- DOI: 10.1038/nprot.2008.92
Generation of human-induced pluripotent stem cells
Abstract
Pluripotent cells, such as embryonic stem cells, are invaluable tools for research and can potentially serve as a source of cell- and tissue-replacement therapy. Rejection after transplantation of cells and tissue derived from embryonic stem cells is a significant obstacle to their clinical use. Recently, human somatic cells have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Human iPS cells are a potential source of patient-specific pluripotent stem cells that would bypass immune rejection. iPS cells can also be used to study diseases for which there are no adequate human in vitro or animal models. In this protocol, we describe how to establish primary human fibroblasts lines and how to derive iPS cells by retroviral transduction of reprogramming factors. Overall, it takes 2 months to complete reprogramming human primary fibroblasts starting from biopsy.
Similar articles
-
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.Nat Biotechnol. 2008 Jan;26(1):101-6. doi: 10.1038/nbt1374. Epub 2007 Nov 30. Nat Biotechnol. 2008. PMID: 18059259
-
From fibroblasts to iPS cells: induced pluripotency by defined factors.J Cell Biochem. 2008 Nov 1;105(4):949-55. doi: 10.1002/jcb.21871. J Cell Biochem. 2008. PMID: 18668528 Review.
-
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.Nat Biotechnol. 2008 Nov;26(11):1276-84. doi: 10.1038/nbt.1503. Epub 2008 Oct 17. Nat Biotechnol. 2008. PMID: 18931654
-
Human iPS cell derivation/reprogramming.Curr Protoc Stem Cell Biol. 2009 Jan;Chapter 4:Unit 4A.1. doi: 10.1002/9780470151808.sc04a01s8. Curr Protoc Stem Cell Biol. 2009. PMID: 19170021
-
Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.J Cell Biochem. 2008 Nov 1;105(4):940-8. doi: 10.1002/jcb.21912. J Cell Biochem. 2008. PMID: 18773452 Review.
Cited by
-
Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.Curr Gene Ther. 2013 Apr;13(2):139-51. doi: 10.2174/1566523211313020008. Curr Gene Ther. 2013. PMID: 23320477 Free PMC article. Review.
-
A review of Rett syndrome (RTT) with induced pluripotent stem cells.Stem Cell Investig. 2016 Sep 28;3:52. doi: 10.21037/sci.2016.09.05. eCollection 2016. Stem Cell Investig. 2016. PMID: 27777941 Free PMC article. Review.
-
Optimization of scarless human stem cell genome editing.Nucleic Acids Res. 2013 Oct;41(19):9049-61. doi: 10.1093/nar/gkt555. Epub 2013 Jul 31. Nucleic Acids Res. 2013. PMID: 23907390 Free PMC article.
-
Transcriptional signature and memory retention of human-induced pluripotent stem cells.PLoS One. 2009 Sep 18;4(9):e7076. doi: 10.1371/journal.pone.0007076. PLoS One. 2009. PMID: 19763270 Free PMC article.
-
Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.Fac Rev. 2022 Jun 28;11:16. doi: 10.12703/r/11-16. eCollection 2022. Fac Rev. 2022. PMID: 35865413 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials